Five pharma companies are represented on the Consumer Health Committee:
|Gemma Codina Tena||Sanofi Consumer Health|
|Suzy Migray||Boehringer Ingelheim|
|Katja Reinhardt||Merck Group|
|Sapan Amin||Pfizer Consumer Healthcare|
‘EphMRA Full Members working together to ensure that OTC data and systems provide the most suitable platform for international secondary market research in Consumer Health.
By liaising with suppliers the committee aims to improve existing OTC data and systems in terms of quality and greater transparency of content.’
Committee activities will include:
The first priority of the Consumer Health Committee has been to liaise with IMS on OTC panel coverage. Currently the committee is working with IMS to gain a comprehensive picture of OTC panel definitions, structure, collection methods and channel coverage and to suggest improvements.
The committee will also be working with IMS to look at OTC classification issues and country-specific issues such as the flagging of Traditional Chinese Medicines in the China panel.
The Consumer Health Committee has also been making contact with other OTC data providers and will be working to inform EphMRA membership on the range of OTC data services available.
The committee would be very pleased to receive enquiries from other Full Members wishing to help improve OTC data sources and systems.
If you would like to contribute, please contact Bernadette Rogers on [email protected]